-
Haloprogin: Evidence from a 1970 Topical Study
2026-08-19
The 1970 study established Haloprogin as a topical antimicrobial with dermatophyte activity comparable to tolnaftate, while also showing activity against Candida species and selected Gram-positive bacteria. Its paired in vitro, formulation, and guinea pig infection experiments provide a useful framework for interpreting spectrum, matrix effects, and topical efficacy.
-
IEM 1460: AMPA Receptor Blocker Guide
2026-08-19
IEM 1460 is a selective AMPA receptor blocker for neuroscience research on excitatory signaling, excitotoxicity, and synaptic transmission. This guide separates product specifications from indirect evidence involving the related compound IEM-1925 in a rat soman model.
-
LY-411575 Workflow for Aβ and Notch Studies
2026-08-18
Build reproducible Alzheimer’s disease and cancer research workflows around LY-411575 by pairing Aβ or NICD measurements with cell-health and functional controls. The guide covers solvent handling, dose design, neuronal validation, Notch assays, and troubleshooting for interpreting pathway inhibition without overclaiming selectivity.
-
NF 340: A Mechanistic Map of P2Y11 Signaling
2026-08-18
NF 340 is a selective P2Y11 antagonist for testing purinergic control of cell migration, myosin light-chain phosphorylation, and cancer invasiveness. This mechanistic guide connects the product’s chemistry and handling requirements with evidence-based assay design and careful causal interpretation.
-
hCG, H3K27me3, and CXCL10 in Decidua
2026-08-17
The reference study shows that human chorionic gonadotropin suppresses CXCL10 in human decidual stromal cells by promoting EZH2-dependent H3K27me3 deposition at the CXCL10 promoter. This chromatin-based mechanism links placental hormone signaling with selective CD8 T-cell recruitment and provides a framework for studying immune regulation at the maternal-fetal interface.
-
JHU-083: A Redox-Aware Glutaminase Strategy
2026-08-17
JHU-083 is a 6-diazo-5-oxo-L-norleucine precursor for selective glutaminase pathway research. This article shows how to combine compartment-specific glutamate measurements with redox and cell-death assays, using recent GSTA1 findings to improve interpretation in neurological models.
-
NHS-Biotin: From Labeling Chemistry to Protein Systems
2026-08-16
NHS-Biotin connects precise amine-reactive chemistry with modern protein engineering, enabling researchers to track, detect, and purify antibodies, nanobodies, and intracellular proteins while preserving a pathway toward translationally useful assay control.
-
Thymosin-β4, Notch/NF-κB, and Limb Ischemia
2026-08-15
The reference study shows that thymosin-β4 promotes endothelial angiogenic activity and neovascularization in a mouse model of critical limb ischemia through coordinated Notch and NF-κB pathway regulation. Its combination of gain-of-function experiments, pathway inhibitors, cellular assays, and tissue-level validation provides a useful framework for evaluating mechanistic links between signaling and therapeutic angiogenesis.
-
LRPPRC–Dasatinib Synergy Disrupts Tumor OXPHOS
2026-08-14
A 2026 study identified dasatinib as a synergistic partner for LRPPRC inhibition in OXPHOS-dependent cancer models. Its central innovation is a dual-genome mechanism in which LRPPRC inhibition preferentially disrupts mitochondrial-encoded OXPHOS programs, while dasatinib suppresses nuclear-encoded OXPHOS genes.
-
Danazol Research: Protocols, Models, and Troubleshooting
2026-08-14
Danazol supports controlled studies of steroidogenesis, hypothalamic–pituitary–gonadal axis activity, and androgen receptor signaling. This practical guide connects cell-based assays with a recent rat model of precocious puberty while emphasizing solvent control, exposure design, and phenotype-specific troubleshooting.
-
Pyridostatin TFA: G-Quadruplex Assay Guide
2026-08-13
Pyridostatin TFA gives researchers a practical way to stabilize G-quadruplexes while connecting telomere biology research with cancer and protein-condensation assays. This guide translates product specifications and recent TDP-43 findings into dose planning, controls, workflow choices, and troubleshooting steps.
-
MG-132: Reliable Apoptosis Assay Workflows
2026-08-13
This scenario-driven guide explains how MG-132 (SKU A2585) can improve interpretation of viability, apoptosis, cell-cycle, and oxidative-stress experiments. It connects product-specific handling data with practical controls, dose selection, and recent ROS-related literature for more reproducible laboratory decisions.
-
Super-Enhancers Drive SLC7A11-Linked Disulfidptosis
2026-08-12
The reference study defines a super-enhancer–FOXA1–SLC7A11 regulatory axis that links prostate cancer transcriptional control with disulfidptosis under glucose stress. Its combined genomic, computational, genetic, and functional approach suggests that nutrient-dependent cell death may be exploited through regulatory elements controlling cystine metabolism.
-
Rocket-Like Nanomedicine Restores PDAC Stroma
2026-08-12
Fu et al. developed an acid-responsive, core–shell nanomedicine that first remodels pancreatic tumor stroma and then improves gemcitabine delivery. In a pancreatic ductal adenocarcinoma mouse model, the platform produced marked tumor regression without reported treatment-related side effects, supporting stromal homeostasis restoration as an alternative to nonspecific stromal ablation.
-
BOP Reagent for Peptide and Prodrug Workflows
2026-08-11
BOP reagent provides a practical route to carboxyl group activation, amide bond formation, and phenyl ester preparation in research-scale synthesis. This workflow-focused guide connects peptide coupling control with assay planning for carrier-free triterpene prodrug research in oral squamous cell carcinoma.